Management of the patient with intermittent claudication

Schroll M. , Munock O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60 year old men and women. J Chron Dis 1981; 34: 261-69.

Kannel WD , Shurtleff D. The Framingham Study. Cigarettes and the development of intermittent claudication . Geriatrics 1973; 28: 61-68.

Hughson WG , Mann JI , Tibbs DJ , Woods HF , Walton I. Intermittent claudication: factors determining outcome. Br Med J 1978; 1: 377-79.

Kannel WB , McGee DL Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 1985; 33: 13-28.

Schadt DC , Hines EA Jr , Juergens JL et al. Chronic atherosclerotic occlusion of the femoral artery. JAMA 1961; 175: 937.

Imparato AM , Kim G. , Davidson T. et al. Intermittent claudication: its natural course. Surgery 1975; 78: 795.

Juergens JL , Barker NW , Hines EA Jr. Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors. Circulation 1960; 21: 188.

Olin JW , Young JR , Graor RA The changing spectrum of thromboangiitis obliterans (Buerger's disease). Circulation 1989; 80 (suppl 11): 11-226.

Kannel WB , Skinner JJ Jr, Schwartz MJ , Shurtleff D. Intermittent claudication. Incidence in the Framingham Study. Circulation 1970; 41: 875.

Hertzer NR , Beven EG , Young JR et al. Coronary artery disease in peripheral vascular patients. Ann Surg 1984; 199: 223-33.

Quill DS , Colgan MP , Sumner DS Ultrasonic screening for the detection of abdominal aortic aneurysms. Surg Clin North Am 1989; 69: 713-20.

Lederie FA , Walker JM , Reinke DB Selective screening for abdominal aortic aneurysms with physical examination and ultrasound. Arch Intern Med 1988; 148: 1753-56.

Szilagyi DE , Schwartz RL , Reddy DJ Popliteal artery aneurysms. Arch Surg 1981; 116: 724-28.

Vermilion BD , Kimmins SA , Pace WG , Evans WE A review of one hundred forty-seven popliteal aneurysms with long-term follow-up. Surgery 1981; 90: 1009-14.

Wychulis AR , Spittell JA , Wallace RB Popliteal aneurysms. Surgery 1970; 68: 942-52.

WoodBurne RT In: Essentials of human anatomy, fifth edition. Oxford: Oxford University Press , 1975: 573.

Weis AV , Fairbairn JF II. Trauma, ischemic limbs, and amputation. Postgrad Med 1968; 43: 111.

Larsen OA , Lassen NA Effect of daily muscular exercise in patients with intermittent claudication . Lancet 1966; ii: 1093-96.

Ericsson B. , Haeger K. , Lindell SE Effect of training on intermittent claudication . Angiology 1970; 21: 188-92.

Ernst EE , Matrai A. Intermittent claudication, exercise, and blood rheology. Circulation 1987; 76: 1110-14.

Mannarino E. , Pasqualini L. , Menna M. , Marogoni G. , Orland U. Effect of physical training on peripheral vascular disease: a controlled study. Angiography 1989; 40: 5-10.

Radack K. , Wyderski RJ Conservative management of intermittent claudication. Ann Intern Med 1990; 113: 135-46.

Dahilof AG , Bjorntorp P. , Holm J. , Schersten T. Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency. Eur J Clin Invest 1974; 4: 9-15.

Myers KA , King RB , Scott DF , Johnson N. , Morris PJ The effect of smoking on the late patency of arterial reconstruction in the legs. Br J Surg 1978; 65: 267-71.

Juergens J. , Barker H. , Hines E. Atherosclerosis obliterans. Review of 520 cases with special reference to pathogenic and prognostic factors. Circulation 1960; 21: 188-95.

Cronenwett JL , Warner KG , Zelnock GM et al. Intermittent claudication. Current results of nonoperative management. Arch Surg 1984; 119: 430-36.

Jonason T. , Ringqvist I. Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication. Acta Med Scand 1985; 218: 27-33.

Tonnessen P. , Fryd V. , Hansen M. et al. Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med 1988; 318: 15-18.

Sutton S. , Hallett R. Randomized trial of brief individual treatment for smoking using nicotine chewing gum in a workplace setting. Am J Public Health 1987; 77: 1210-11.

Oster G. , Huse DM , Delea TE et al. Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking. JAMA 1986 ; 256: 1315-18.

Verbeuren TH , Jordaens FH , Zonnekeyn LL , VanHove GE, Coene MC, Herman AG. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ Res 1986; 58: 552-64.

Yamamoto H. , Bossaller C. , Cartwright J Jr , Henry PD Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit. J Clin Invest 1988; 81: 1752-58.

Shimokawa H. , Kim P. , Vanhoutte PM Endothelium-dependent relaxation to aggregating platelets in isolated basilar arteries of control and hypercholesterolemic monkeys. Circ Res 1988; 63: 604-12.

Osborne JA , Siegman MJ , Sedar AW , Mooers SU , Efer AM Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol 1989 ; 256 (Cell Physiol 25): C591-597.

Andrews HE , Bruckdorfer KR , Dunn RC , Jacobs M. Low-density lipoproteins inhibit endothelium-dependent relaxation rabbit aorta . Nature 1987; 327: 237-39.

Cohen RA , Zitnay KM , Haudenschild CC , Cunningham LD Loss of selective endothelial cells vasoactive functions in pig coronary arteries caused by hypercholesterolemia. Circ Res 1988 ; 63: 903-10.

Girerd XJ , Hirsch AT , Cooke JP , Creager MA L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res (in press).

Moncada S. , Herman AG , Higgs EA , Vane JR Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium . Thromb Res 1977; 11: 323-44.

Furchgott RF , Zawadzki JV The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-76.

Stamler JS , Mendelsohn ME , Amarante P. , Smick D. , Andon N. , Davies PF , Cooke JP , Loscalzo J. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 1989; 65: 789-95.

Garg UC , Hassid A. Nitric oxide generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 823: 1774-77.

D'Angelo V. , Villa S. , Mysliwiec M. , Donati MB , de Gaetano G. Defective fibrinolytic and prostacyclin-like activity in human atheromatous plaques. Thromb Haemost 1978; 39: 535-36.

Osborne JA , Lento PH , Siegfried MR , Stahl GL , Fusman B. , Lefer AM Cardiovascular effects of acute hypercholesterolemia in rabbits: reversal with lovastatin treatment. J Clin Invest 1989 ; 83: 465-73.

Harrison DG , Armstrong ML , Freiman PC , Heistad DD Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987; 80: 1808-11.

Blankenhorn DH , Brooks SH , Selzer RH et al. The rate of atherosclerosis change during treatment of hyperlipoproteinemia. Circulation 1978; 57: 355.

Levy RI , Quarfort SH , Brown WV et al. The efficacy of clofibrate (CPIB) in familial hyperlipoproteinemia . In: Holmes WL , Carlso CA , Paoletti R eds. Advances in experimental medicine and biology, volume 4. New York: Plenum Press, 1969: 377.

Zelis R. , Mason DT , Braunwald E. et al. Effects of hyperlipoproteinemias and their treatment on the peripheral circulation. J Clin Invest 1970 ; 49: 1007.

Ost CR , Stenson S. Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid. Scand J Clin Lab Invest 1967 ; 93: 241.

Knight L. , Scheibel R. , Amplatz K. et al. Radiographic appraisal of the Minnesota partial ileal by-pass study. Surg Forum 1972; 23: 141.

Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351-64.

Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 365-74.

Kromhout D. , Bosschieter EB , de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease . N Engl J Med 1985; 312: 1205-1209.

Nelson AM Diet therapy in coronary disease: effect on mortality of high-protein, high-seafood, fat-controlled diet. Geriatrics 1972; 27 (12): 103-16.

Bang HO , Dyerberg J. Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med Scand 1972; 192: 85-94.

Dyerberg J. , Bang HO Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979; ii: 433-35.

Philipson BE , Rothrock DW , Conner WE , Harris WJ , Illingworth DR Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985; 312: 1210-16.

Knapp HR , Reilly Iag , Alessandrini P. , Fitzgerald GA In Vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 1986; 314: 937-42.

Shimokawa H. , Vanhoutte PM Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic prone coronary arteries . Circulation 1988; 78: 1421-30.

Weiner BH , Ockene IS , Levine PH et al. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. N Engl J Med 1986; 315: 841-46.

Veterans Administration Cooperative Study Group on Antihypertensive Agents : effect of treatment on morbidity in hypertension. Results in patients with diastolic blood pressure averaging 115 through 129 mmHg. JAMA 1967; 202: 116-22.

Veterans Administration Cooperative Study Group on Antihypertensive Agents : effect of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970; 213: 1143-52.

Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. JAMA 1979 ; 242: 2562-71.

Hiatt WR , Stall S. , Nies AS Effect of β-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease. Circulation 1985; 72: 1226-31.

Coffman JD Vasodilator drugs in peripheral vascular disease. N Engl J Med 1979; 300: 713-17.

Habib JB , Bossaller C. , Wells S. , Williams C. , Morrisett JD , Henry PD Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110. Circ Res 1986; 58: 305-309.

Sugano M. , Nakaghima Y. , Tasaki H. , Fakasugi M. , Kuroiwa A. , Koide O. Effects of diltiazem on suppression and regression of experimental atherosclerosis. Br J Exp Pathol 1988; 69: 515-23.

Malone JM , Moore WS , Goldstone J. Life expectancy following aortofemoral arterial grafting. Surgery 1977; 81: 551.

DeWeese JA , Rob CG Autogenous venous grafts ten years later. Surgery 1977; 82: 775.

Strandness DE Jr, Priest RE , Gibbons GE Combined clinical and pathologic study of diabetic and nondiabetic peripheral arterial disease. Diabetes 1964; 13: 366.

LoGerfo FW , Coffman JD Vascular and microvascular disease of the foot in diabetes. N Engl J Med 1984; 311: 1615-19.

Cahill GE Jr , Etzwiler DD , Freinkel N. 'Control' and diabetes. N Engl J Med 1976; 294: 1004.

Camerini-Davalos RA , Velasco C. , Glasser M. , Bloodworth Jmb. Drug-induced reversal of early diabetic microangiopathy. N Engl J Med 1983; 309: 1551-56.

Boers Ghj , Smals Agh , Trijbels Fjm et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313: 709-15.

Steering Committee of The Physician's Health Study Research Group. Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 1989; 321: 129-35.

Chesebro JH , Fuster V. , Elveback LR et al. Effect of dipyridamole and aspirin on late vein graft patency after coronary bypass operations. N Engl J Med 1984; 310: 209-14.

FitzGerald GA. Dipyridamole. N Engl J Med 1987; 316: 1247-56.

Coffman JD , Mannick JA Failure of vasodilator drugs in arteriosclerosis obliterans. Ann Intern Med 1972; 76: 35-59.

Creager MA , Roddy M. The effect of nifedipine on calf blood flow and exercise capacity in patients with intermittent claudication. J Vasc Med Biol (in press).

Janicek MJ , Hollenberg NK Responses to ketanserin in patients with peripheral vascular disease: implications of collateral arterial function. Circulation 1988; 78: 11-404.

Prevention of Atherosclerotic Complications with Ketanserin Trial Group. Prevention of atherosclerotic complications: controlled trial of ketanserin. Br Med J 1989; 298: 424-30.

PACK Claudication Substudy Investigators. Randomized placebo-controlled, double-blind trial of ketanserin in claudicants: changes in claudication distance and ankle systolic pressure . Circulation 1989; 80: 1544-48.

Buckert D. , Harwart D. Trials of 3,7-dimethyl-1-(5-oxohexyl) xanthine in double-blind tests. Farmaco 1976; 31: 264-74.

Schubotz R. Double-blind trial of pentoxifylline in diabetics with peripheral vascular disorders. Pharmatherapeutica 1976; 1: 172-79.

Angelkort B. Influence of pentoxifylline on microcirculation poststenotic blood pressure and walking capacity in patients with chronic occlusive arterial disease. IRCS Med Sci 1977 ; 5: 370-74.

Bollinger A. , Frei C. Double-blind study of pentoxifylline against placebo in patients with intermittent claudication. Pharmatherapeutica 1977; 1: 557-62.

Porter JM , Cutler BS , Lee BY et al. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J 1982; 104: 66-72.

Dormandy JA , Hoare E, Colley et al. Clinical, haemodynamic, rheological and biochemical findings in 126 patients with intermittent claudication. Br Med J 1973; 4: 576-81.